AusCann is an Australian company focused on the development and commercialisation of cannabinoid-derived therapeutic products to address unmet needs for humans and animals within Australia and internationally. Our key difference is the commitment to rigorous product development, focused on providing reliable, stable and standardised cannabinoid-derived therapeutic solutions to people and pets.
Cann Group Limited
Business sector: Medicinal Cannabis
Established in 2014, Cann Group is an Australian-based leader in medicinal cannabis with a focus on local cultivation and manufacture of GMP medical products. Our research and development focus aims to deliver enhanced medical cannabis products designed to meet the needs of patients in Australia and around the world. Through ongoing research, and the experience of medical practitioners and patients, we will continue to expand on our product pipeline of unique medical products designed to address specific needs and improve peoples’ quality of life. We currently have a white label product range available for immediate supply within Australia and globally and look forward to discussing your requirements.
Cymra Life Sciences
Business sector: Genetics, Propagation Services, Breeding, Tissue
Cymra Life Sciences aims to support Australian growers with all their genetic supply and support services. We can help you with Genetics, Tissue Culture, Breeding services and propagation of clones to your site.
Business sectors: Contract Manufacturer, API and White Label service
MediPharm Labs is a fully licensed B2B contract manufacturer offering pharmaceutical-grade cannabinoid preparations and API. The company’s Australian facility is TGA-GMP certified for API a range of finished dose formats.
MedReleaf Australia is licensed to cultivate, import, warehouse and manufacture medical cannabis by the Federal Government’s Office of Drug Control (ODC). The company has a strategic partnership with Aurora Cannabis Enterprises and is backed by more than 40 years of pharmaceutical and healthcare expertise, driven by research and product development, and is striving to make improvements to the health of Australian patients.
We dedicate ourselves to innovation and operational excellence. A distinct business positioned to take advantage of a rapidly growing market built to service the Australian medical industry including Doctors, Pharmacists and allied health professionals
Business sector: Cultivator / GMP Certified Producer
Our company is an Australian operated medicinal cannabis cultivation and production facility based in Tasmania. We are AU-GMP licenced to produce oral liquids and dried herb products for inhalation under the Tasmanian Botanics brand.
Zelira Therapeutics Ltd is a leading global biopharmaceutical company manufacturing and marketing cannabinoid-based medicines. Zelira owns a portfolio of proprietary revenue generating products and a pipeline of candidates undergoing clinical development that are positioned to access the world’s largest and fastest growing markets.